Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schuster

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Genetic Epidemiology|March 21, 2000
Linkage analysis of 150 high-risk prostate cancer families at 1q24-25E L Goode, J L Stanford, L Chakrabarti, et al.
Ebiomedicine|August 19, 2022
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancerMilana A Bergamino, Elena López-Knowles, Gabriele Morani, et al.
Environmental Pollution (Barking, Essex : 1987)|April 15, 2008
Comparison of total mercury and methylmercury cycling at five sites using the small watershed approachJames B Shanley, M Alisa Mast, Donald H Campbell, et al.
International Journal of Biometeorology|July 24, 2002
Analysis of the growth of rimu (Dacrydium cupressinum) in South Westland, New Zealand, using process-based simulation modelsDavid Whitehead, Graeme M J Hall, Adrian S Walcroft, et al.
NPJ Breast Cancer|July 1, 2024
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studiesMaggie Chon U Cheang, Mothaffar Rimawi, Stephen Johnston, et al.
Journal of Medicinal Chemistry|September 15, 2009
Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetesGregory R Bebernitz, Valerie Beaulieu, Bethany A Dale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2019
Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy ResistanceAlex Pearson, Paula Proszek, Javier Pascual, et al.
Nature Communications|June 29, 2023
The proteomic landscape of soft tissue sarcomasJessica Burns, Christopher P Wilding, Lukas Krasny, et al.
Cancer Research|July 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast CancerFrancisco Hermida-Prado, Yingtian Xie, Shira Sherman, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Genetic Epidemiology|March 21, 2000
Linkage analysis of 150 high-risk prostate cancer families at 1q24-25E L Goode, J L Stanford, L Chakrabarti, et al.
Ebiomedicine|August 19, 2022
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancerMilana A Bergamino, Elena López-Knowles, Gabriele Morani, et al.
Environmental Pollution (Barking, Essex : 1987)|April 15, 2008
Comparison of total mercury and methylmercury cycling at five sites using the small watershed approachJames B Shanley, M Alisa Mast, Donald H Campbell, et al.
International Journal of Biometeorology|July 24, 2002
Analysis of the growth of rimu (Dacrydium cupressinum) in South Westland, New Zealand, using process-based simulation modelsDavid Whitehead, Graeme M J Hall, Adrian S Walcroft, et al.
NPJ Breast Cancer|July 1, 2024
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studiesMaggie Chon U Cheang, Mothaffar Rimawi, Stephen Johnston, et al.
Journal of Medicinal Chemistry|September 15, 2009
Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetesGregory R Bebernitz, Valerie Beaulieu, Bethany A Dale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2019
Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy ResistanceAlex Pearson, Paula Proszek, Javier Pascual, et al.
Nature Communications|June 29, 2023
The proteomic landscape of soft tissue sarcomasJessica Burns, Christopher P Wilding, Lukas Krasny, et al.
Cancer Research|July 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast CancerFrancisco Hermida-Prado, Yingtian Xie, Shira Sherman, et al.
Pageof 15